Clinical trial · Observational
Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
The Vulnerable Elders Survey Study of Older Cancer Patients
NCT00740961CI-TRIAL-00046206terminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): low accrual
Summary
Brief summary (as posted)
RATIONALE: Learning about changes over time in older patients' ability to function after receiving chemotherapy for breast or colon cancer may help doctors learn about the long-term effects of treatment and plan the best treatment. PURPOSE: This clinical trial is studying older patients with newly diagnosed breast cancer or colon cancer.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Cognitive/Functional Effects | — | UNRESOLVED | — |
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
| Psychosocial Effects of Cancer and Its Treatment | — | UNRESOLVED | — |
Interventions
Interventions (7)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| cognitive assessment | Procedure | — | UNRESOLVED |
| compliance monitoring | Behavioral | — | UNRESOLVED |
| medical chart review | Other | — | UNRESOLVED |
| psychosocial assessment and care | Procedure | — | UNRESOLVED |
| study of socioeconomic and demographic variables | Other | — | UNRESOLVED |
| survey administration | Other | — | UNRESOLVED |
| systemic chemotherapy | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Patients with cancer
- description
- Patients ≥ 65 years with new stage I-III breast or colon cancer seeking care. Patients will be matched on baseline scores, age and sex. Patients will be age and sex matched due to the known relation between inflammatory markers and demographic characteristics39,40, and will be matched on baseline VES scores to ensure similar baseline VES-13 scores between groups and which will then allow us to then assess effect of cancer treatment on outcomes.
- interventionNames
- Behavioral: compliance monitoring
- Drug: systemic chemotherapy
- Other: medical chart review
- Other: study of socioeconomic and demographic variables
- Other: survey administration
- Procedure: cognitive assessment
- Procedure: psychosocial assessment and care
- label
- Patients without cancer
- description
- non-cancer patients, seeking care at out-patient clinics
- interventionNames
- Behavioral: compliance monitoring
- Other: medical chart review
- Other: study of socioeconomic and demographic variables
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 65 Years
Show eligibility criteria text
DISEASE CHARACTERISTICS: * Histologically confirmed breast or colon cancer * Newly diagnosed disease * Any stage disease * Undergoing treatment at the Ireland Cancer Center, University Hospitals Case Medical Center Site * Scheduled to start a new chemotherapy regimen (objective II only) * Not concurrently enrolled in a GEM trial (objectives II, III, and IV) * Hormone receptor status not specified PATIENT CHARACTERISTICS: * Understands English * Menopausal status not specified PRIOR CONCURRENT THERAPY: * See Diseases Characteristics
References
Publications (0)
Data not yet available
No reference posted for this study.